Topoisomerase inhibitors

Details Topoisomerase inhibitors Topoisomerase inhibitors

2006-11-21

2006-11-21

Lewis, Patrick (Department: 1623)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Carbohydrate doai

C514S042000, C536S018700, C536S022100, C536S027100, C536S028600

Reexamination Certificate

active

07138377

ABSTRACT:
The present invention concerns novel sugar derivatives of indolocarbazoles and pharmaceutical formulations thereof which exhibit topoisomerase-I activity and are useful in inhibiting the proliferation of tumor cells.

REFERENCES:
patent: 4487925 (1984-12-01), Nettleton, Jr. et al.
patent: 4552842 (1985-11-01), Nettleton, Jr. et al.
patent: 4567143 (1986-01-01), Matson
patent: 4785085 (1988-11-01), Kaneko et al.
patent: 5043335 (1991-08-01), Kleinschroth et al.
patent: 5407940 (1995-04-01), Bisagni et al.
patent: 5468849 (1995-11-01), Lam et al.
patent: 5468872 (1995-11-01), Glicksman et al.
patent: 5475110 (1995-12-01), Hudkins et al.
patent: 5478813 (1995-12-01), Okanishi et al.
patent: 5498611 (1996-03-01), Bisagni et al.
patent: 5589365 (1996-12-01), Kojiri et al.
patent: 5618809 (1997-04-01), Barrabee et al.
patent: 5668271 (1997-09-01), Kojiri et al.
patent: 5674867 (1997-10-01), Tamaoki et al.
patent: 6037468 (2000-03-01), Wood et al.
patent: 6653290 (2003-11-01), Ruediger et al.
patent: 0 450 327 (1991-10-01), None
patent: 0602597 (1993-12-01), None
patent: 0545195 (1995-11-01), None
patent: 1101770 (2001-05-01), None
patent: 203758 (1991-09-01), None
patent: 211254 (1995-11-01), None
patent: 217611 (2000-03-01), None
patent: WO 89/07105 (1989-10-01), None
patent: WO 95/30682 (1995-11-01), None
patent: WO 96/04293 (1996-02-01), None
patent: WO 96/11933 (1996-04-01), None
patent: WO 98/07433 (1998-02-01), None
patent: WO 99/02532 (1999-01-01), None
Gonzalez, et al.,Farmacia Clinica(1997), 14: 250.
Long, et al.,American Association for Cancer Research Proceedings(1997), 38: 75.
Madden, et al.,Cancer Research(1992), 52: 525.
O'Connor, et al.,Cancer Communications(1990), 2: 395.
Pollack, et al.,Molecular Pharmacology(1999), 56: 185.
Prudhomme, M.,Current Medicinal Chemistry(2000), 7: 1189.
B. B. Shankar et al.,Tetrahedron Lett. (1994), 35: 3005.
B. M. Stolz et al.,Tetrahedron Lett. (1995), 36: 8543.
J. Anizon et al.,Bioorg. &Med. Chem. (1998), 6: 1597.
S.W. McCombie et al.,Bioorg. &Med. Chem. Lett. (1993), 8: 1537.
C. Bailly et al,Biochemistry(1997), 36: 3917.
D. Von Hoff et al.,Cancer Chemother., Pharmacol. (1994), 34 (suppl): S41.
T. Yoshinari et al.,Cancer Research(1993), 53: 490.
T. Yoshinari et al.,Cancer Research(1995), 55: 1310.
D.A. Scudiero et al.,Cancer Research(1988), 48: 4827.
E.R. Pereira et al.,J. Med. Chem. (1996), 39: 4471.
Greene and Wuts, Protective Groups in Organic Synthesis, 2ndEd., John Wiley and Sons and McOmie, New York, 1991.
J. L. Wood et al.,J. Am. Chem. Soc. (1995), 117: 10413.
J. T. Link et al.,J. Am. Chem. Soc. (1996), 118: 2825.
R. Kobayoshi et al.,J. Am. Chem. Soc. (1999), 121: 6501.
A. Mazur et al.,J. Org. Chem. (1997), 62: 4471.
K. Nowak et al.,Roczniki Chem. (1996), 43: 1953.
M. Gallant et al.,J. Org. Chem. (1993), 58: 343.
M.S. Motawia et al.,J. Carbohydrate Chemistry(1995), 14(9): 1279.
R.L. Halcomb et al.,J. Amer. Chem. Soc. (1989), 111: 6661.
Nicolaou et al.,J. Amer. Chem. Soc. (1989), 111: 6666.
S. F. Vice et al.,Bioorg. Med. Chem. Lett. (1994), 4: 1333.
T. Hayashi et al.,Bioorganic And Medicinal Chemistry(1997), 5(3): 497.
Weinreb et al.,Heterocycles(1984), 21: 309.
Y.-H. Hsiang et al.,J. Biol. Chem. (1985), 260(27): 14873.

Affiliated with

Also associated with

Rating

Topoisomerase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Topoisomerase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Topoisomerase inhibitors will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3703314